Experts offer in-depth insights on clinical topics vital to the practice of dermatology, including biosimilar swapping, advances in understanding immunomodulatory drugs in skin cancers, benefits and timing of lymph node dissection following biopsy, and the role of IL-31 in atopic dermatitis.

MauiDerm 2017

How psoriasis arisesThe research road to streamlining the model of psoriasis pathogenesis.
Checkpoint inhibitors flourishKey publications from the past year have enhanced our understanding of immunomodulatory drugs for advanced and metastatic skin cancers. Others could portend significant practice changes in areas such as sentinel lymph node (SLN) biopsy, says one dermatologist
IL-31 at center stageA novel interleukin (IL) antagonist currently in phase 2 studies could advance the treatment of atopic dermatitis (AD), according to dermatologist.
Biosimilar familiarity expandsDermatologists and some psoriasis patients might soon grapple with switching from a biologic to a biosimilar.
Atopic dermatitis comorbiditiesEmerging data suggest that atopic dermatitis is not just a skin disease. In terms of its impact on the whole patient and its potential for multi-organ involvement, it is a systemic disease, according to one dermatologist.